CLX Investment Company Announces Secure Storage of Zonda, Inc. Chlamydia Tests with Sentry Logistic Solutions in Preparation for Clinical Trails

MURRIETA, CA--(Marketwire - January 22, 2008) - CLX Investment Company, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that in preparation for planned clinical trials for Zonda's rapid point of care test for Chlamydia, the tests that will be used in the trials have been placed in an FDA compliant, GMP approved secure storage facility provided by Sentry Logistic Solutions ("Sentry"), a leading provider of temperature-controlled storage and third party logistics.